Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prenetics Global Limited - Class A Ordinary Share (NQ:PRE)

18.60 -3.14 (-14.44%)
Streaming Delayed Price Updated: 12:51 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Prenetics Global Limited - Class A Ordinary Share

< Previous 1 2 3 Next >
News headline image
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Formula 1 Phenom Ollie Bearman Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Reinforces Strategic Focus on IM8, Divests Europa Business For Up to $13 Million
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Provides Update on Voluntary Warrant Exchange Program, Reaching 86.7% Participation
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Announces Upcoming Conference Participation
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics’ IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Announces $48.0 Million Equity Offering to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Global Limited Announces Proposed Public Offering
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics’ IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Completes $72 Million ACT Exit, Bolsters Cash and Bitcoin Treasury to Accelerate IM8’s Path to $100 Million ARR
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year’s End
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics’ IM8 Congratulates Global Ambassador and Shareholder - World No. 1 Aryna Sabalenka on Defending Her US Open Championship
From Prenetics Global Limited
Via GlobeNewswire
News headline image
World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction
From Prenetics Global Limited
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.